How much sun can (and should) I get?

by Katie Lee and Rachel Neale,The ConversationCredit: Unsplash/CC0 Public DomainAs we slide of out summer, you might be wondering how careful you need to be about sun exposure. Excessive exposur

Updated on: March 30,2024

How much sun can (and should) I get?

by Katie Lee and Rachel Neale,The ConversationCredit: Unsplash/CC0 Public DomainAs we slide of out summer, you might be wondering how careful you need to be about sun exposure. Excessive exposur

Updated on:March 30,2024

Blood test for brain cancer may be on horizon, research finds

byPennsylvania State UniversityCredit: Pixabay/CC0 Public DomainGlioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at

Updated on: January 23,2024

Blood test for brain cancer may be on horizon, research finds

byPennsylvania State UniversityCredit: Pixabay/CC0 Public DomainGlioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at

Updated on:January 23,2024

Newfound cancer cell biology suggests which patients will respond to immunotherapy

byNYU Langone HealthCredit: Pixabay/CC0 Public DomainPatients with head and neck cancer who have more genetic material on chromosome 9 in their cancer cells survive three times longer after rece

Updated on: January 13,2024

Newfound cancer cell biology suggests which patients will respond to immunotherapy

byNYU Langone HealthCredit: Pixabay/CC0 Public DomainPatients with head and neck cancer who have more genetic material on chromosome 9 in their cancer cells survive three times longer after rece

Updated on:January 13,2024

How 'paralyzed' immune cells can be reactivated against brain tumors

by German Cancer Research CenterGlioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0Brain tumor cells with a certain common mutation reprogram

Updated on: April 01,2024

How 'paralyzed' immune cells can be reactivated against brain tumors

by German Cancer Research CenterGlioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0Brain tumor cells with a certain common mutation reprogram

Updated on:April 01,2024

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

by Lauran NeergaardThis combination of MRI scan images provided by theNew England Journal of Medicinein March 2024 shows the progress of a glioblastoma patient who received CAR-T therapy w

Updated on: March 20,2024

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

by Lauran NeergaardThis combination of MRI scan images provided by theNew England Journal of Medicinein March 2024 shows the progress of a glioblastoma patient who received CAR-T therapy w

Updated on:March 20,2024

Meningioma molecular profile reliably predicts tumor recurrence

by Baylor College of MedicineCredit: CC0 Public DomainAlthough typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The

Updated on: March 12,2024

Meningioma molecular profile reliably predicts tumor recurrence

by Baylor College of MedicineCredit: CC0 Public DomainAlthough typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The

Updated on:March 12,2024

Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with a type of breast cancer called HER2-positive are less likely to survive if their initial tr

Updated on: February 24,2024

Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with a type of breast cancer called HER2-positive are less likely to survive if their initial tr

Updated on:February 24,2024

Cesarean section tied to higher risk for later leukemia in offspring

Elective cesarean section (CS) is associated with an increased risk for leukemia in offspring, according to a systematic review and meta-analysis published online Aug. 24 inHematological Oncolog

Updated on: January 02,2024

Cesarean section tied to higher risk for later leukemia in offspring

Elective cesarean section (CS) is associated with an increased risk for leukemia in offspring, according to a systematic review and meta-analysis published online Aug. 24 inHematological Oncolog

Updated on:January 02,2024

Exploring novel mechanisms and therapeutic targets for acute myeloid leukemia

by Melissa Rohman,Northwestern UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainPatients with acute myeloid leukemia, the most common type of adult blood cancer, show

Updated on: January 07,2024

Exploring novel mechanisms and therapeutic targets for acute myeloid leukemia

by Melissa Rohman,Northwestern UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainPatients with acute myeloid leukemia, the most common type of adult blood cancer, show

Updated on:January 07,2024

Stopping the resistance of cancer cells to treatment

by Colin Poitras,University of ConnecticutCredit: CC0 Public DomainOne of the drawbacks of chemotherapy is that cancer patients can build up resistance to treatment over time, increasing their c

Updated on: April 01,2024

Stopping the resistance of cancer cells to treatment

by Colin Poitras,University of ConnecticutCredit: CC0 Public DomainOne of the drawbacks of chemotherapy is that cancer patients can build up resistance to treatment over time, increasing their c

Updated on:April 01,2024

Exercise associated with benefit to patients with advanced colorectal cancer

by Dana-Farber Cancer InstituteDr. Meyerhardt is the clinical director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute and the senior author of the study. Credit: Dana-Farbe

Updated on: May 05,2024

Exercise associated with benefit to patients with advanced colorectal cancer

by Dana-Farber Cancer InstituteDr. Meyerhardt is the clinical director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute and the senior author of the study. Credit: Dana-Farbe

Updated on:May 05,2024

Researchers renew obsolete concept by using folate for cancer drug delivery

by Raymond A. Macdougall,National Institutes of HealthImages of cancer tumor cells taken with a confocal laser scanning microscope. The top row of images show that the anti-cancer formulation de

Updated on: June 15,2024

Researchers renew obsolete concept by using folate for cancer drug delivery

by Raymond A. Macdougall,National Institutes of HealthImages of cancer tumor cells taken with a confocal laser scanning microscope. The top row of images show that the anti-cancer formulation de

Updated on:June 15,2024